24-Oct-2012 - Waters Corporation

Waters Corporation Reports Third Quarter 2012 Results

Waters Corporation reported third quarter 2012 sales of $450 million, a 1% decrease in comparison to sales of $455 million in the third quarter of 2011. For the quarter, foreign currency translation reduced sales growth by 3%. On a GAAP basis, earnings per diluted share (E.P.S.) for the third quarter were $1.12 compared to $1.10 for the third quarter in 2011. On a non-GAAP basis, E.P.S. were up 4% to $1.18 in the third quarter of 2012 from $1.14 in the third quarter of 2011. A reconciliation of GAAP to non-GAAP E.P.S. is attached.

Through the first nine months of 2012, sales for the Company were $1,322 million, a decline of 1% in comparison to sales of $1,330 million in the first nine months of 2011. Foreign currency translation reduced sales growth during the first nine months of 2012 by 3%. E.P.S. for the first nine months of 2012 were $3.19 compared to $3.18 for the comparable period in 2011. On a non-GAAP basis and including adjustments on the attached reconciliation, E.P.S. grew 3% in the first nine months of 2012 to $3.35 from $3.26 in 2011.

Commenting on the quarter, Douglas Berthiaume, Chairman, President and Chief Executive Officer said, “Stable pharmaceutical demand and strong sales in Asia allowed us to organically grow our revenue in the third quarter despite challenging market conditions. At the same time, tight expense control, disciplined product pricing and a continuation of our share repurchase program resulted in adjusted earnings per share growth at a rate faster than sales.”

Facts, background information, dossiers
  • Waters
More about Waters